ask="N/A"
ask_size="N/A"
average_daily_volume="37947"
bid="1.5000"
bid_size="100"
book_value="0.0000"
change="+0.0101"
change_from_200_day_moving_average="0.1741"
change_from_50_day_moving_average="0.9586"
change_from_52_week_high="-8.7399"
change_From_52_week_low="1.9101"
change_in_percent="+0.2220%"
close="4.5601"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.2650"
ebitda="0.00"
eps_estimate_current_year="-5.0600"
eps_estimate_next_quarter="-0.7000"
eps_estimate_next_year="-2.2800"
ex_dividend_date="N/A"
float_shares="N/A"
high="4.8900"
high_52_weeks="13.3000"
last_trade_date="2/3/2017"
last_trade_price="4.5601"
last_trade_size="200"
last_trade_time="3:59pm"
low="4.5510"
low_52_weeks="2.6500"
market_capitalization="N/A"
moving_average_200_day="4.3860"
moving_average_50_day="3.6015"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="6.7500"
open="4.6500"
pe_ratio="N/A"
peg_ratio="-0.0200"
percent_change_from_200_day_moving_average="+3.9702%"
percent_change_from_50_day_moving_average="+26.6160%"
percent_change_from_52_week_high="-65.7135%"
percent_change_from_52_week_low="+72.0792%"
previous_close="4.5500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NCM"
symbol="CLBS"
volume="29202"
weeks_range_52="2.6500 - 13.3000"
